COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,944 Articles (22,604 medRxiv, 8,340 bioRxiv)

Most recent first Previous |  Page 1150: Articles 11491-11500  | Next

Clinical observation of high-flow nasal cannula (HFNC) with non-rebreather mask (NRM) use on severe or critically ill COVID-19 diabetic patients
Bhuiyan, A. T., Nath, S. D., Das, S., Das, M., Biswas, R., Ahsan, M., Ziad, M. I.-E.-A., Padma, F. K., Dey, R., Alam, A. S., Zehan, F. H., Saha, A.
10.1101/2021.10.13.21264946 — Posted: 2021-10-18
Predicting COVID-19 Vaccine Efficacy from Neutralizing Antibody Levels
Abedi, M. R., Dixon, S., Guyon, T., Hsu, S., Jacobs, A. R., Nair, L., Terbrueggen, R.
10.1101/2021.10.13.21264921 — Posted: 2021-10-18
COVID-19 Likelihood Meter: a machine learning approach to COVID-19 screening for Indonesian health workers
Sonthalia, S., Muharrom, M. A., Sani, L. L., Herlinda, O., Bella, A., Swashtika, D., Hadisoemarto, P., Saminarsih, D., Lutungan, N., Irwanto, A., Taher, A., Greenstein, J. L.
10.1101/2021.10.15.21265021 — Posted: 2021-10-18
How frequent are acute reactions to COVID-19 vaccination and who is at risk?
Dreyer, N. A., Reynolds, M. W., Albert, L. M., Brinkley, E., Kwon, T., Mack, C. D., Toovey, S.
10.1101/2021.10.14.21265010 — Posted: 2021-10-18
Agile design and development of a high throughput cobas(R) SARS-CoV-2 RT-PCR diagnostic test
Manohar, C., Sun, J., Schlag, P., Santini, C., Fontecha, M., Lotscher, P., Bier, C., Goepfert, K., Duncan, D., Spier, G., Jarem, D., Kosarikov, D.
10.1101/2021.10.13.21264919 — Posted: 2021-10-18
A Thermostable Cas12b from Brevibacillus Leverages One-pot Detection of SARS-CoV-2 Variants of Concern
Nguyen, L. T., Macaluso, N. C., Pizzano, B. L. M., Cash, M. N., Spacek, J., Karasek, J., Dinglasan, R. R., Salemi, M., Jain, P. K.
10.1101/2021.10.15.21265066 — Posted: 2021-10-18
A high content microscopy-based platform for detecting antibodies to the nucleocapsid, spike and membrane proteins of SARS-CoV-2
Williams, D. M., Hornsby, H., Shehata, O. M., Brown, R., Zafred, D., Shun-Shion, A. S. M., Hodder, A. J., Bliss, D., Metcalfe, A., Edgar, J., Gordon, D. E., Sayers, J. R., Nicklin, M. J., Collini, P. J., Brown, S., de Silva, T. I., Peden, A. A.
10.1101/2021.10.14.21264873 — Posted: 2021-10-18
Molecular evidence of coinfection with acute respiratory viruses and high prevalence of SARS-CoV-2 among patients presenting flu-like illness in Bukavu city, Democratic Republic of Congo
Bisimwa, P. N., Basengere, R. A., Baharanyi, T. C., Kashosi, T. M., Buhendwa, J.-P. C., Bisimwa, P. B., Kusinza, A. B., Mugumaarhahama, Y., Shukuru, D. W., Patrick, S. B., Tonui, R., Birindwa, A. B., Mukwege, D.
10.1101/2021.10.16.21265044 — Posted: 2021-10-18
Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease.
Wellens, J., Edmans, M., Obolski, U., McGregor, C. G., Simmonds, P., Turner, M., Jarvis, L., Skelley, D., Dunachie, S., Eyre, D. W., Colombel, J.-F., Wong, S.-Y., Klenerman, P., Lindsey, J. O., Satsangi, J., Thompson, C. P.
10.1101/2021.10.13.21264916 — Posted: 2021-10-18
Comparative effectiveness of ChAdOx1 versus BNT162b2 COVID-19 vaccines in Health and Social Care workers in England: a cohort study using OpenSAFELY
Hulme, W. J., Williamson, E. J., Green, A. C., Bhaskaran, K., McDonald, H. I., Rentsch, C. T., Schultze, A., Tazare, J., Curtis, H. J., Walker, A. J., Tomlinson, L., Palmer, T. M., Horne, E., MacKenna, B., Morton, C. E., Mehrkar, A., Fisher, L., Bacon, S. C., Evans, D., Inglesby, P., Hickman, G., Davy, S., Ward, T., Croker, R., Eggo, R. M., Wong, A. Y., Mathur, R., Wing, K., Forbes, H., Grint, D. J., Douglas, I. J., Evans, S. J., Smeeth, L., Bates, C., Cockburn, J., Parry, J., Hester, F., Harper, S., Sterne, J. A., Hernan, M. A., Goldacre, B.
10.1101/2021.10.13.21264937 — Posted: 2021-10-18 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).